Mabswitch is a biotechnology company that focuses on the development and commercialization of innovative products in the healthcare sector. The company's main offerings include the development of regulatable antibodies that are used as next-generation immunotherapeutics, diagnostics, and immunoaffinity reagents. These products primarily cater to the biopharmaceutical industry.
